Skip to content

Clinical study on pressing needle to treat hyperplasia of mammary glands

Clinical study on pressing needle to treat hyperplasia of mammary glands

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016489
Enrollment
Unknown
Registered
2018-06-04
Start date
2018-07-01
Completion date
Unknown
Last updated
2018-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperplasia of mammary glands

Interventions

Sponsors

Beijing First Hospital of Integrated Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. women between the ages of 18 and 40 have regular menstrual cycles (28 days plus or MINUS 3 days) and menses; 2. vas > level 3 patients; 3. those who did not receive treatment for hyperplasia of mammary glands within one month, and those who did not use hormone preparations within half a year; 4. informed consent, volunteers and signatories of informed consent.

Exclusion criteria

Exclusion criteria: (1) allergic constitution, scar constitution or serious skin diseases; (2) those who have received other related treatments that may affect the observation indicators of this study; (3) pregnancy, lactation, menopause and women preparing for pregnancy; (4) patients with breast cancer, inflammatory diseases and other endocrine diseases; (5) complicated with cardiovascular and cerebrovascular diseases, liver, kidney, hematopoietic system and other serious primary diseases, or psychotic patients.

Design outcomes

Primary

MeasureTime frame
Breast Pain;

Secondary

MeasureTime frame
Breast Lump;Syndrome of liver depression and qi stagnation;

Countries

China

Contacts

Public ContactWang Xiao-feng

Beijing First Hospital of Integrated Chinese and Western Medicine

1405002169@qq.com+86 18600934266

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026